Antagonistic Effects of Gestational Dietary Exposure to Low-dose Vinclozolin and Genistein on Rat Fetal Germ Cell Development
Overview
Toxicology
Authors
Affiliations
Continuous, low-dose exposure to a phytoestrogen (1 mg/kg/day genistein) and/or to an antiandrogenic food contaminant (1 mg/kg/day vinclozolin) has been recently reported to affect male reproductive tract and fertility [1] in adults. We investigated whether alterations of the testis are already present at the end of in utero exposure using the same rat model and doses following exposure from conception to delivery. After vinclozolin exposure, we observed in the neonate a slight but significant alteration of steroidogenesis and gametogenesis with a reduction of testosterone secretion and of the number of gonocytes. In contrast, genistein exposure had no effect. While the vinclozolin-genistein mixture acts in a synergistic manner to induce the most significant alterations in the adult, interestingly, genistein antagonized the deleterious effect of vinclozolin on germ cells in the neonate. This difference emphasizes the importance of studying the effects of endocrine disruptors during various developmental stages to understand their effects.
Elcombe C, Evans N, Bellingham M Crit Rev Toxicol. 2022; 52(3):221-238.
PMID: 35894754 PMC: 9530410. DOI: 10.1080/10408444.2022.2091423.
Estrogenic Pastures: A Source of Endocrine Disruption in Sheep Reproduction.
Pool K, Chazal F, Smith J, Blache D Front Endocrinol (Lausanne). 2022; 13:880861.
PMID: 35574027 PMC: 9097266. DOI: 10.3389/fendo.2022.880861.
Boudalia S, Bousbia A, Boumaaza B, Oudir M, Canivenc Lavier M Bioimpacts. 2021; 11(4):289-300.
PMID: 34631491 PMC: 8494257. DOI: 10.34172/bi.2021.33.
Endocrine-disrupting chemicals and male reproductive health.
Sharma A, Mollier J, Brocklesby R, Caves C, Jayasena C, Minhas S Reprod Med Biol. 2020; 19(3):243-253.
PMID: 32684823 PMC: 7360961. DOI: 10.1002/rmb2.12326.
Androgen receptor and soy isoflavones in prostate cancer.
Sivonova M, Kaplan P, Tatarkova Z, Lichardusova L, Dusenka R, Jurecekova J Mol Clin Oncol. 2019; 10(2):191-204.
PMID: 30680195 PMC: 6327222. DOI: 10.3892/mco.2018.1792.